Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-05-04
1979-05-08
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424273R, 424274, 424313, 424316, 424318, 424319, A61K 31195, A61K 31215, C07C10384
Patent
active
041537254
ABSTRACT:
New carboxyalkylacylamino acids which have the general formula ##STR1## are useful as angiotensin converting enzyme inhibitors.
REFERENCES:
patent: 3462535 (1969-08-01), Loew et al.
patent: 3551419 (1970-12-01), Re et al.
patent: 3852338 (1974-12-01), Kaiser et al.
patent: 3896166 (1975-07-01), Kaiser et al.
Berse et al., J. Org. Chem., vol. 27, 1962, pp. 3489-3495.
Vasilevskii et al., Zh, Org. Khimii, vol. 2, 1970, pp. 244-249.
Cushman David W.
Ondetti Miguel A.
E. R. Squibb & Sons Inc.
Fagelson Anna P.
Levinson Lawrence S.
Smith Merle J.
LandOfFree
Relieving angiotension related hypertension with carboxyalkylacy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Relieving angiotension related hypertension with carboxyalkylacy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Relieving angiotension related hypertension with carboxyalkylacy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1234014